[ 8 ] Kohnert KD, Augstein P, Zander E, et al. Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents[J]. Diabetes Care, 2009, 32(6): 1058-1062.
[2]
[ 9 ] Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes[J]. JAMA, 2006, 295(14): 168l-1687.
[3]
Brownlee M. The pathobiology of diabetic complications: a unifying mechanism[J]. Diabetes, 2005, 54(6): 1615-1625.
[4]
Kowluru RS. Role of interleukin-1 beta in the pathogenesis of diabetic retinopathy[J]. Br J Ophthalmol, 2004, 88(10): 1343-1347.
[5]
Navarro JF, Mora-Fernandz C. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeatic implications[J]. Cytokine Growth Factor Rev, 2006, 17(6): 441-450.
Varma R, Macias GL, Torres M, et al. Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study[J]. Ophthalmology, 2007, 114(7): 1332-1340.
[ 6 ] Hattori Y, Suzuki M, Hattori S, et al. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts)[J]. Hypertension, 2002, 39(1): 22-28.
[16]
[ 7 ] Ceriello A, Esposito K, Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients[J]. Diabetes, 2008, 57(5): 1349-1354.
